Afuco™ Anti-Human PADI2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-PADI2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-PAD2 antibodies are used in the treatment of autoimmune diseases characterized by extracellular citrullination, such as rheumatoid arthritis (RA).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-712CL |
| Pricing | Inquiry |
| Host | Human |
| Target | PADI2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |